HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Denis Angoulvant Selected Research

Pneumonia (Pneumonitis)

12/2019Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
4/2014Lack of group X secreted phospholipase A₂ increases survival following pandemic H1N1 influenza infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Denis Angoulvant Research Topics

Disease

43Myocardial Infarction
01/2024 - 06/2005
26ST Elevation Myocardial Infarction
01/2024 - 02/2008
25Infarction (Infarctions)
01/2024 - 08/2005
19Stroke (Strokes)
11/2022 - 04/2008
17Atrial Fibrillation
08/2023 - 07/2012
13Heart Failure
01/2024 - 03/2005
10Ischemia
10/2023 - 06/2007
10Cardiovascular Diseases (Cardiovascular Disease)
06/2023 - 01/2016
10Hemorrhage
01/2022 - 11/2013
8Thrombosis (Thrombus)
01/2024 - 11/2013
7Coronary Artery Disease (Coronary Atherosclerosis)
12/2021 - 07/2012
6Inflammation (Inflammations)
10/2023 - 06/2012
5Ischemic Stroke
01/2024 - 01/2016
5Reperfusion Injury
09/2015 - 07/2008
4Acute Coronary Syndrome
06/2023 - 06/2015
4Diabetes Mellitus
05/2022 - 11/2014
4Myocardial Ischemia (Ischemic Heart Diseases)
12/2019 - 06/2005
3Neoplasms (Cancer)
07/2022 - 06/2014
3Human Influenza (Influenza)
06/2022 - 04/2014
3Macular Degeneration (Age-Related Maculopathy)
11/2021 - 11/2014
3Necrosis
06/2021 - 01/2017
3Shock
05/2021 - 11/2020
3Cardiogenic Shock
03/2021 - 12/2018
3Ventricular Remodeling
09/2015 - 04/2008
2Fibrosis (Cirrhosis)
10/2023 - 11/2020
2Coronary Disease (Coronary Heart Disease)
06/2023 - 11/2009
2Atherosclerosis
01/2023 - 12/2019
2Breast Neoplasms (Breast Cancer)
01/2022 - 06/2014
2Hypertension (High Blood Pressure)
01/2022 - 11/2014
2COVID-19
05/2021 - 12/2020
2Hypoxia (Hypoxemia)
01/2021 - 07/2015
2Chronic Kidney Failure (Chronic Renal Failure)
02/2020 - 07/2012
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2020 - 12/2019
2Pneumonia (Pneumonitis)
12/2019 - 04/2014
2Wounds and Injuries (Trauma)
01/2019 - 07/2015
2Chest Pain (Chest Pains)
10/2018 - 02/2008
2Retinal Vein Occlusion
01/2018 - 11/2014
2Macular Edema
01/2018 - 11/2014
2Mitral Valve Stenosis (Mitral Stenosis)
01/2016 - 10/2015
2Body Weight (Weight, Body)
09/2015 - 07/2008
2Infections
04/2014 - 06/2006
2Cicatrix (Scar)
02/2009 - 11/2005
2Heart Diseases (Heart Disease)
03/2008 - 03/2005
1Frailty
01/2023
1Hyperemia
02/2022

Drug/Important Bio-Agent (IBA)

10Creatine Kinase (Creatine Phosphokinase)IBA
07/2022 - 06/2007
7omega-Chloroacetophenone (Mace)IBA
12/2021 - 07/2012
7Biomarkers (Surrogate Marker)IBA
06/2021 - 02/2008
7Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2021 - 07/2008
6ColchicineFDA LinkGeneric
01/2024 - 12/2019
6Proteins (Proteins, Gene)FDA Link
10/2023 - 06/2006
6Vitamin KFDA Link
01/2017 - 05/2015
5LipidsIBA
12/2023 - 12/2021
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 07/2006
5Troponin IIBA
12/2020 - 06/2007
4Purinergic Receptors (Receptors, Purine)IBA
10/2023 - 07/2015
4Adenosine Triphosphate (ATP)IBA
06/2020 - 06/2014
4AnticoagulantsIBA
10/2018 - 11/2013
3LDL CholesterolIBA
12/2023 - 12/2019
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2023 - 07/2012
3CreatinineIBA
01/2022 - 11/2009
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2021 - 11/2013
3CytokinesIBA
12/2019 - 03/2008
2oxidized low density lipoproteinIBA
12/2023 - 06/2023
2CholesterolIBA
01/2023 - 01/2020
2VaccinesIBA
06/2022 - 01/2020
2TicagrelorIBA
09/2021 - 01/2019
2Morphine (MS Contin)FDA LinkGeneric
05/2021 - 10/2018
2Monoclonal AntibodiesIBA
12/2019 - 11/2014
2DabigatranFDA Link
11/2016 - 03/2016
2APTIBA
01/2016 - 08/2015
2IsoenzymesIBA
01/2016 - 03/2014
2MB Form Creatine KinaseIBA
01/2016 - 03/2014
2Mitochondrial Permeability Transition PoreIBA
08/2014 - 06/2007
2EnzymesIBA
04/2014 - 02/2008
1eicosapentaenoic acid ethyl esterIBA
06/2023
1Triglycerides (Triacylglycerol)IBA
06/2023
1Ezetimibe (Zetia)FDA Link
06/2023
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2022
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
11/2022
1Insulin (Novolin)FDA Link
05/2022
1regadenosonFDA Link
02/2022
1Dipyridamole (Persantine)FDA LinkGeneric
02/2022
1Indicators and Reagents (Reagents)IBA
01/2022

Therapy/Procedure

25Therapeutics
12/2023 - 03/2005
24Percutaneous Coronary Intervention
07/2022 - 02/2008
8Stents
01/2022 - 07/2012
4Secondary Prevention
12/2021 - 01/2018
3Defibrillators (Defibrillator)
06/2021 - 01/2020
3Length of Stay
10/2020 - 01/2016
3Heart Transplantation (Grafting, Heart)
01/2020 - 01/2019
3Ischemic Postconditioning
03/2014 - 02/2008
3Cell Transplantation
11/2005 - 03/2005
2Drug-Eluting Stents
10/2022 - 07/2012
2Artificial Heart (Artificial Hearts)
01/2016 - 10/2015
2Patient Readmission
09/2015 - 06/2015
1Sympathectomy (Sympathectomies)
01/2024
1Oral Administration
01/2024
1Catheter Ablation
08/2023
1Polypharmacy
01/2023